This inventor holds 3 USPTO granted patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 1987-1994.
Company Filing History:
Years Active: 1987-1994
Title: Bernhard Eggimann: Innovator in Affinity Peptide Technology
Introduction
Bernhard Eggimann is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of affinity peptides and fusion proteins. With a total of 3 patents, Eggimann's work has advanced the methods of protein purification.
Latest Patents
Eggimann's latest patents focus on affinity peptides and fusion proteins. His inventions include a process for their purification using metal chelate affinity chromatography on NTA resins. This innovative approach enhances the efficiency and effectiveness of protein purification, which is crucial in various biotechnological applications.
Career Highlights
Eggimann is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at this esteemed organization has allowed him to further his research and development in the field of biotechnology. His contributions have been instrumental in advancing the understanding and application of affinity peptides.
Collaborations
Throughout his career, Eggimann has collaborated with esteemed colleagues such as Erich Hochuli and Dietrich Stuber. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Bernhard Eggimann's work in affinity peptide technology exemplifies the impact of innovative thinking in biotechnology. His patents and collaborations continue to influence the field, paving the way for future advancements.